A Phase 2 Study Evaluating Safety and Tolerability of RCT2100 (CFTR mRNA) in Healthy Participants and in Participants With CF
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- John Matthews, MBBS, MCRP, PhD
ReCode Therapeutics, Inc.
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
23 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Centre Hospitalier Régional Universitaire de Montpellier - Hôpital Arnaud de Villeneuve
Montpellier, France
Recruiting - Hôpital Necker Enfants Malades
Paris, France
Recruiting
- Umc Utrecht
Utrecht, Netherlands
Recruiting
- New Zealand Clinical Research (part 1 Only)
Auckland, New Zealand
Completed
- University Hospitals Birmingham
Birmingham, United Kingdom
Recruiting - Royal Papworth Hospital
Cambridge, United Kingdom
Recruiting - Leeds Teaching Hospitals
Leeds, United Kingdom
Recruiting - King'S College Hospital
London, United Kingdom
Recruiting - Nottingham University Hospitals
Nottingham, United Kingdom
Recruiting - University Hospital Southampton
Southampton, United Kingdom
Recruiting
- the University of Alabama at Birmingham
Birmingham, Alabama, United States
Recruiting - University of Arizona
Tucson, Arizona, United States
Recruiting - Stanford University
Palo Alto, California, United States
Recruiting - Ucsd
San Diego, California, United States
Recruiting - National Jewish Health
Denver, Colorado, United States
Recruiting - Emory University
Atlanta, Georgia, United States
Recruiting - Boston Children'S Hospital
Boston, Massachusetts, United States
Recruiting - New York Medical College
Valhalla, New York, United States
Recruiting - the University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, United States
Recruiting - Oregon Health & Science University
Portland, Oregon, United States
Recruiting - University of Pittsburgh
Pittsburgh, Pennsylvania, United States
Recruiting - Ut Southwestern Medical Center
Dallas, Texas, United States
Recruiting - University of Washington
Seattle, Washington, United States
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Feb 2024
- Primary completion
- 30 Aug 2026
- Completion
- 31 Dec 2026
- Last update posted
- 16 Jan 2026
- Registered enrollment
- 192
- Registry id
- NCT06237335
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.